PubRank

Priti Kumar

Author PubWeight™ 22.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One 2007 5.43
2 RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Mol Ther 2009 1.55
3 Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 2005 1.54
4 Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Mol Ther 2010 1.28
5 Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production. J Virol 2009 1.06
6 Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids. Chem Biol 2011 1.05
7 Interfering antiviral immunity: application, subversion, hope? Trends Immunol 2006 1.03
8 Health impact assessment needs in south-east Asian countries. Bull World Health Organ 2003 0.97
9 Conditional RNAi: towards a silent gene therapy. Adv Drug Deliv Rev 2009 0.95
10 Identification and functional analysis of the primary pantothenate transporter, PfPAT, of the human malaria parasite Plasmodium falciparum. J Biol Chem 2013 0.92
11 Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA. Biomaterials 2011 0.90
12 Humanized mice for studying human leukocyte integrins in vivo. Methods Mol Biol 2012 0.85
13 Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized Mice. Mol Ther Nucleic Acids 2013 0.83
14 RNA-based gene therapy for the treatment and prevention of HIV: from bench to bedside. Yale J Biol Med 2011 0.82
15 Single chain variable fragment CD7 antibody conjugated PLGA/HDAC inhibitor immuno-nanoparticles: developing human T cell-specific nano-technology for delivery of therapeutic drugs targeting latent HIV. J Control Release 2011 0.81
16 Effective suppression of HIV-1 by artificial bispecific miRNA targeting conserved sequences with tolerance for wobble base-pairing. Biochem Biophys Res Commun 2008 0.81
17 Effective gene delivery into human stem cells with a cell-targeting Peptide-modified bioreducible polymer. Small 2014 0.77
18 Cell-specific siRNA delivery by peptides and antibodies. Methods Enzymol 2012 0.76
19 Organization of flaviviral replicase proteins in virus-induced membranes: a role for NS1' in Japanese encephalitis virus RNA synthesis. Novartis Found Symp 2006 0.76
20 Delivering antiviral siRNA into human T-cells: New approaches in RNAi-based HIV therapy. IDrugs 2009 0.75
21 β-Galactosidase. Cold Spring Harb Protoc 2017 0.75
22 Cationic cell-penetrating peptides as vehicles for siRNA delivery. Ther Deliv 2015 0.75
23 Arginine-grafted biodegradable polymer: a versatile transfection reagent for both DNA and siRNA. Methods Mol Biol 2014 0.75
24 Transfection of Mammalian Cells with Calcium Phosphate-DNA Coprecipitates. Cold Spring Harb Protoc 2019 0.75
25 Assay for β-Galactosidase in Extracts of Mammalian Cells. Cold Spring Harb Protoc 2017 0.75
26 Calcium Phosphate-Mediated Transfection of Adherent Cells or Cells Growing in Suspension: Variations on the Basic Method. Cold Spring Harb Protoc 2019 0.75
27 Calcium Phosphate-Mediated Transfection of Cells with High-Molecular-Weight Genomic DNA. Cold Spring Harb Protoc 2019 0.75
28 Calcium Phosphate-Mediated Transfection of Eukaryotic Cells with Plasmid DNAs. Cold Spring Harb Protoc 2019 0.75